EGFR and neoplasm: QRH-882260 is an orally bioavailable heptapeptide imaging agent labeled with the fluorophore cyanine 5.5 (Cy5.5) linked to the 7 aa peptide that binds specifically to the epidermal growth factor receptor, EGFR, and is used to image EGFR-expressing tumor cells.